ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced the launch of its Early Access Express License, a new licensing option designed to support early stage innovators at ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Gene editing has enormous potential to help feed the world’s growing population, but it’s currently difficult, time-consuming ...
Dr Constantinos Patinios, a researcher at the EMBL Partnership Institute at Vilnius University Life Sciences Center (VU LSC), ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Researchers used CRISPR gene editing to improve an Indian soybean variety, boosting levels of a healthier fat called oleic ...
Agriculture faces unprecedented challenges from environmental pressures and increasing demand for food production. As global ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.
Changing climatic conditions are imposing various biotic, such as new pests and diseases, and abiotic, such as heat, drought, salinity, crop lodging, and water logging, stresses, which significantly ...
A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.
At 3 months old, Victoria Gray wouldn’t stop crying. Blood tests brought devastating news: she had sickle cell disease, a genetic blood disorder that blocks blood flow and oxygen delivery to the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results